Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared Raffaele Colombo’s post on X, adding:
“Appreciate the shout‑out for our clinical trials symposium, Raffaele Colombo!
Precision oncology isn’t a monarchy, it’s democracy in action, powered by data, collaboration, and patients. Precision medicine for the win.
Thanks to AACR for the honor of inviting us to chairing the clinical trials session.”
Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared a post on X:
“King and queen of precision medicine chairing the Clinical Trials Minisymposium in hall H!
Vivek Subbiah and Jia Jenny Liu.”
More posts about AACR 2026.